Wells Fargo & Company Catalent, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Catalent, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 12,734 shares of CTLT stock, worth $778,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,734

Previous 50,450 74.76%

Holding current value

$778,174

Previous $2.84 Million 72.81%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $2.12 Million - $2.3 Million	-37,716 Reduced 74.76%	12,734 $771,000
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $2.24 Million - $2.38 Million	41,781 Added 481.96%	50,450 $2.84 Million
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $2.33 Million - $3.28 Million	-54,780 Reduced 86.34%	8,669 $489,000
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $390,246 - $564,754	12,127 Added 23.63%	63,449 $2.85 Million
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $1.7 Million - $1.93 Million	-38,515 Reduced 42.87%	51,322 $2.34 Million
Q2 2023 Aug 15, 2023	SELL	$31.86 - $67.26 $136,998 - $289,218	-4,300 Reduced 4.57%	89,837 $3.9 Million
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $1.29 Million - $2.11 Million	-28,424 Reduced 23.19%	94,137 $6.19 Million
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $937,110 - $1.83 Million	-22,641 Reduced 15.59%	122,561 $5.51 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $765,858 - $1.2 Million	-10,584 Reduced 6.79%	145,202 $10.5 Million
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $4.05 Million - $5.3 Million	-46,481 Reduced 22.98%	155,786 $16.7 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $1 Million - $1.33 Million	-10,660 Reduced 5.01%	202,267 $22.4 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $1.62 Million - $1.89 Million	-13,589 Reduced 6.0%	212,927 $27.3 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $6.93 Million - $9.03 Million	-63,456 Reduced 21.88%	226,516 $30.1 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $5.61 Million - $6.47 Million	-55,894 Reduced 16.16%	289,972 $31.4 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $90.4 Million - $112 Million	-890,698 Reduced 72.03%	345,866 $36.4 Million
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $2.3 Million - $2.82 Million	26,801 Added 2.22%	1,236,564 $129 Million
Q3 2020 Nov 05, 2020	SELL	$72.74 - $92.5 $5.43 Million - $6.9 Million	-74,586 Reduced 5.81%	1,209,763 $104 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $5.41 Million - $8.91 Million	-112,738 Reduced 8.07%	1,284,349 $94.1 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $51.6 Million - $87.9 Million	1,397,087 New	1,397,087 $72.6 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Catalent, Inc. Transaction History